Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM)

Meletios A. Dimopoulos; Judith Trotman; Alessandra Tedeschi; Jeffrey V. Matous; David Macdonald; Constantine Tam; Oliver Tournilhac; Shuo Ma; Albert Oriol; Leonard T. Heffner; Chaim Shustik; Ramón García-Sanz; Robert F. Cornell; Carlos Fernández de Larrea; Jorge J. Castillo; Miquel Granell; Marie-Christine Kyrtsonis; Veronique Leblond; Argiris Symeonidis; Priyanka Singh; Jianling Li; Thorsten Graef; Elizabeth Bilotti; Steven Treon; Christian Buske

doi:10.1182/BLOOD.V126.23.2745.2745

Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM)

Meletios A. Dimopoulos
, Judith Trotman
, Alessandra Tedeschi
, Jeffrey V. Matous
, David Macdonald
, Constantine Tam
, Oliver Tournilhac
, Shuo Ma
, Albert Oriol
, Leonard T. Heffner
, Chaim Shustik
, Ramón García-Sanz
, Robert F. Cornell
, Carlos Fernández de Larrea
, Jorge J. Castillo
, Miquel Granell
, Marie-Christine Kyrtsonis
, Veronique Leblond
, Argiris Symeonidis
, Priyanka Singh

Jianling Li, Thorsten Graef, Elizabeth Bilotti, Steven Treon, Christian Buske

National and Kapodistrian University of Athens
University of Sydney
Division of Hematology, Niguarda Cà Granda Hospital, Milan, Italy
Colorado Blood Cancer Institute, Denver, CO
Dalhousie University
Peter MacCallum Cancer Centre
Hématologie Clinique Adulte et Thérapie Cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand, France
Northwestern University
Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
Emory University
McGill University Health Centre
Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
Vanderbilt University
Department of Hematology, Amyloidosis and Myeloma Unit, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
Harvard University
Department of Hematology, Hospital Sant Pau, Barcelona, Spain
University of Paris
University of Patras
Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
University of Ulm

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	126
Issue number	23
DOIs	https://doi.org/10.1182/BLOOD.V126.23.2745.2745
State	Published - Dec 3 2015
Externally published	Yes

Disciplines

Medicine and Health Sciences
Family Medicine

Access to Document

10.1182/BLOOD.V126.23.2745.2745License: Unspecified

Cite this

Dimopoulos, M. A., Trotman, J., Tedeschi, A., Matous, J. V., Macdonald, D., Tam, C., Tournilhac, O., Ma, S., Oriol, A., Heffner, L. T., Shustik, C., García-Sanz, R., Cornell, R. F., de Larrea, C. F., Castillo, J. J., Granell, M., Kyrtsonis, M.-C., Leblond, V., Symeonidis, A., ... Buske, C. (2015). Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM). Blood, 126(23). https://doi.org/10.1182/BLOOD.V126.23.2745.2745

Dimopoulos, MA, Trotman, J, Tedeschi, A, Matous, JV, Macdonald, D, Tam, C, Tournilhac, O, Ma, S, Oriol, A, Heffner, LT, Shustik, C, García-Sanz, R, Cornell, RF, de Larrea, CF, Castillo, JJ, Granell, M, Kyrtsonis, M-C, Leblond, V, Symeonidis, A, Singh, P, Li, J, Graef, T, Bilotti, E, Treon, S & Buske, C 2015, 'Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM)', Blood, vol. 126, no. 23. https://doi.org/10.1182/BLOOD.V126.23.2745.2745

@article{5034943ffdf54261abfac435978baa13,

title = "Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenstr{\"o}m's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM)",

author = "Dimopoulos, \{Meletios A.\} and Judith Trotman and Alessandra Tedeschi and Matous, \{Jeffrey V.\} and David Macdonald and Constantine Tam and Oliver Tournilhac and Shuo Ma and Albert Oriol and Heffner, \{Leonard T.\} and Chaim Shustik and Ram{\'o}n Garc{\'i}a-Sanz and Cornell, \{Robert F.\} and \{de Larrea\}, \{Carlos Fern{\'a}ndez\} and Castillo, \{Jorge J.\} and Miquel Granell and Marie-Christine Kyrtsonis and Veronique Leblond and Argiris Symeonidis and Priyanka Singh and Jianling Li and Thorsten Graef and Elizabeth Bilotti and Steven Treon and Christian Buske",

note = "624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II | Meletios A. Dimopoulos, Judith Trotman, Alessandra Tedeschi, Jeffrey V. Matous, David Macdonald, Constantine Tam, Oliver Tournilhac, Shuo Ma, Albert Oriol, Leonard T. Heffner, Chaim Shustik, Ram{\'o}n Garc{\'i}a-Sanz, Robert F. Cornell, Carlos Fern{\'a}ndez de Larrea, Jorge J.",

year = "2015",

month = dec,

day = "3",

doi = "10.1182/BLOOD.V126.23.2745.2745",

language = "American English",

volume = "126",

journal = "Blood",

publisher = "American Society of Hematology",

number = "23",

}

TY - JOUR

T1 - Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM)

AU - Dimopoulos, Meletios A.

AU - Trotman, Judith

AU - Tedeschi, Alessandra

AU - Matous, Jeffrey V.

AU - Macdonald, David

AU - Tam, Constantine

AU - Tournilhac, Oliver

AU - Ma, Shuo

AU - Oriol, Albert

AU - Heffner, Leonard T.

AU - Shustik, Chaim

AU - García-Sanz, Ramón

AU - Cornell, Robert F.

AU - de Larrea, Carlos Fernández

AU - Castillo, Jorge J.

AU - Granell, Miquel

AU - Kyrtsonis, Marie-Christine

AU - Leblond, Veronique

AU - Symeonidis, Argiris

AU - Singh, Priyanka

AU - Li, Jianling

AU - Graef, Thorsten

AU - Bilotti, Elizabeth

AU - Treon, Steven

AU - Buske, Christian

N1 - 624. Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models: Poster II | Meletios A. Dimopoulos, Judith Trotman, Alessandra Tedeschi, Jeffrey V. Matous, David Macdonald, Constantine Tam, Oliver Tournilhac, Shuo Ma, Albert Oriol, Leonard T. Heffner, Chaim Shustik, Ramón García-Sanz, Robert F. Cornell, Carlos Fernández de Larrea, Jorge J.

PY - 2015/12/3

Y1 - 2015/12/3

UR - https://ashpublications.org/blood/article/126/23/2745/135577/Ibrutinib-Therapy-in-Rituximab-Refractory-Patients

U2 - 10.1182/BLOOD.V126.23.2745.2745

DO - 10.1182/BLOOD.V126.23.2745.2745

M3 - Article

VL - 126

JO - Blood

JF - Blood

IS - 23

ER -

Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM)

Disciplines

Access to Document

Other files and links

Cite this